oncologysupply.com
New Account
Sign In
Logout
☰
˟
▼
Contact
▼
Customer Service
1-800-633-7555
Email
Nucleus Help Desk
1-877-224-9692
Email
Online Help
1-877-757-7954
Email
Accounting
1-888-877-8430
Email
Join ION Solutions
1-888-536-7697 ext. 3103
Email
Additional Contacts
Account
▼
Admin
View Account
My Profile
Order
Rebates
Reports
Invoices
Favorites
Protocol Analyzer
Nucleus Inventory
Nucleus Connect
Catalog
Site Content
LOGIN FAILED - Invalid User Name / Password. Please Try Again
You have been logged out. Thank you
This is a warning feedback message
Precision Medicine Center
Home
Precision Medicine Center
Precision Medicine Center
Precision by Tumor
Precision by Partner
Genomic Precision
Genetic Precision
Resources
Precision by Tumor
Precision by Tumor
Select a tumor type below to view its testing recommendations.
Breast Cancer
Breast Cancer
NSCLC
NSCLC
Colorectal
Colorectal
Genitourinary
GU (prostate, ovarian, and bladder)
Lymphoma
Lymphoma (mantle cell, DLBCL, lymphoblastic)
Rare Disease
Rare Disease
Testing for Hereditary Risk Assessment
Diagnostic Testing
Prognostic Testing
Testing for Metastatic Disease
Adenocarcinoma, NOS NSCLC, or Large Cell Lung Cancer:
Newly Diagnosed, Early Stage Disease
Advanced/Metastatic Disease at Initial Diagnosis
Advanced/Metastatic Disease at Time of Disease Progression
Squamous NSCLC:
Newly Diagnosed, Early Stage Disease
Advanced/Metastatic Disease
Diagnostic Testing for Stage IIB-IIIA Patients
Diagnostic Testing for All Patients with Metastatic Disease
Diagnostic Testing for Second Line Treatment with I/O Drugs
Genetic High Risk Patients
Prostate Cancer
Ovarian Cancer
Bladder Cancer
Mantle Cell & Follicular Lymphoma
Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) & CD5+ B-cell Lymphoproliferative Disorders
Diffuse Large B-Cell Lymphoma (DLBCL)
Lymphoplasmacytic Lymphoma (LPL), Marginal Zone Lymphoma, and Hodgkin’s Lymphoma
Multiple Myeloma
Rare Disease
Precision by Partner
AbbVie
VENCLEXTA® Patient Support Programs
Starting Patients on VENCLEXTA® in Combination with Rituximab or as Monotherapy
AstraZeneca
AZ Oncology ID: Informing treatment through precision medicine
Request more information or a visit from an AZ representative
Pfizer
Learn About gBRCA Testing for Your Patients
Myriad
Introducing myGeneHistory
All Breast Cancer Patients Now Meet Testing Guidelines
myRisk: Genetic Testing Criteria
Myriad Promise: Expanded Access Postcard
Myriad is ION's Preferred Partner for Best-In-Class Genetic Testing & Services
Myriad Announces the Preferred ION Program
Foundation Medicine
Comprehensive Product Portfolio
FoundationOne CDx and Liquid
Integrate Cancer Genomics into Your Practice
Test Requisition Form
Test Requisition Form Explained
Request more info or get in touch with a Foundation Medicine representative
Adaptive Biotechnologies
clonoSEQ: The First & Only FDA-Cleared Assay for MRD Detection
Adaptive, MRD and clonoSEQ Overview
clonoSEQ: The Power of MRD Testing
What is MRD?
Genomic Precision
Genomic Precision
Genomic analysis is changing the way cancer care is delivered. Our partners are leading this transformation by making precision therapies a reality for patients through comprehensive profiles derived from solid tumor and liquid biopsies.
Guardant Health
Learn more about the Guardant360 liquid biopsy test, with all NCCN somatic genomic targets.
Foundation Medicine
Learn more about Foundation Medicine’s comprehensive genomic profiling assays.
Genetic Precision
Genetic Precision
Genetic tests may be used to identify increased risks of health problems, to choose treatments, or to assess responses to treatments. Our partners offer high-quality genetic testing with thoroughly validated clinical evidence to give our members the answers they need, quickly and reliably.
Myriad
Learn more about Myriad Genetics’ accurate, affordable and clinically significant hereditary cancer tests.
Invitae
Learn more about Invitae’s comprehensive genetic tests offering the broadest oncology catalog.
Resources
Webcast Series:
Breast Cancer Testing Recommendations
Article:
Best Practices for Effective Genomic Testing in Community Oncology
Article:
Biomarkers Drive Advances in Drug Therapy
Precision Medicine Panel
ION Precision Medicine Team
Upcoming Events
Research Opportunities
Precision Medicine Summit Archives
Contact Us